【摘要】：哮喘是一種由環(huán)境和遺傳因素共同作用導(dǎo)致的復(fù)雜疾病,其遺傳率約為36%-79%。2007年,對(duì)哮喘進(jìn)行的第一個(gè)全基因組關(guān)聯(lián)分析發(fā)現(xiàn)了一個(gè)新的哮喘易感基因----ORMDL3。研究者發(fā)現(xiàn)ORMDL3所在的17q21區(qū)域中的遺傳多態(tài)位點(diǎn)與兒童哮喘顯著相關(guān),并且在EB病毒感染的哮喘兒童的淋巴母細(xì)胞系中,該區(qū)域中的遺傳多態(tài)還與ORMDL3基因的表達(dá)水平密切相關(guān)。 ORMDL3基因位于17q21,是ORM基因家族的一員。在酵母中,該家族含有ORMDL1和ORMDL2兩個(gè)成員,而在人類中還有ORMDL3,共三個(gè)家族成員。在酵母中,該基因家族與神經(jīng)鞘磷脂代謝平衡相關(guān),是神經(jīng)鞘磷脂合成過(guò)程中第一個(gè)限速酶的負(fù)調(diào)控者,提示神經(jīng)鞘磷脂代謝可能在哮喘的發(fā)生過(guò)程中具有重要作用。另外,在酵母中敲除ORM基因,表現(xiàn)為生長(zhǎng)緩慢和對(duì)有毒物質(zhì)的敏感性增強(qiáng),這一現(xiàn)象在轉(zhuǎn)染入人類ORMDL3基因的mRNA后得以拯救。ORMDL3基因編碼一個(gè)含有153個(gè)氨基酸的內(nèi)質(zhì)網(wǎng)四次跨膜蛋白,其在人類組織中表達(dá)廣泛,特別是在肝臟和外周血淋巴細(xì)胞中高表達(dá)。研究表明ORMDL3在內(nèi)質(zhì)網(wǎng)上與鈣泵共定位,抑制鈣泵的功能,影響鈣離子平衡并且能夠促進(jìn)內(nèi)質(zhì)網(wǎng)應(yīng)激和未折疊蛋白反應(yīng),表明ORMDL3可能參與內(nèi)質(zhì)網(wǎng)有關(guān)的炎癥反應(yīng)。另外,人們還發(fā)現(xiàn)在兒童臍帶血單核細(xì)胞中17q21區(qū)域中的遺傳多態(tài)不但與ORMDL3, GSDMA基因的表達(dá)水平相關(guān),而且還與IL-17的分泌相關(guān),表明該區(qū)域可能在免疫系統(tǒng)成熟的早期階段與T細(xì)胞的發(fā)育分化有關(guān)。而除了與哮喘相關(guān)之外,人們還發(fā)現(xiàn)ORMDL3與克隆恩病、強(qiáng)直性脊柱炎、系統(tǒng)性紅斑狼瘡、Ⅰ型糖尿病、神經(jīng)膠質(zhì)瘤、原發(fā)性膽汁肝硬化、過(guò)敏性鼻炎等多種炎癥性疾病顯著相關(guān)。 自從發(fā)現(xiàn)ORMDL3是一個(gè)新的哮喘易感基因,在很短的時(shí)間內(nèi),人們又在多個(gè)不同種族人群中進(jìn)行了驗(yàn)證,結(jié)果發(fā)現(xiàn)ORMDL3基因在不同人群中均與兒童哮喘顯著相關(guān)。但是所有這些研究都是在兒童哮喘中進(jìn)行的,那么,ORMDL3基因是否也與成人哮喘相關(guān)呢?在EB病毒感染的哮喘兒童淋巴母細(xì)胞系中17q21上的遺傳多態(tài)與ORMDL3基因的表達(dá)相關(guān),那么在成人哮喘患者的外周血淋巴細(xì)胞中這一現(xiàn)象是否仍然存在呢?哮喘患者體內(nèi)ORMDL3基因的表達(dá)異常是怎樣引起的呢?ORMDL3基因的表達(dá)調(diào)控又是怎樣的呢?帶著這些問(wèn)題,本論文進(jìn)行了以下四個(gè)方面的研究： 第一部分17q21區(qū)域與中國(guó)漢族成人哮喘的關(guān)聯(lián)分析 為了明確ORMDL3基因所在的17q21區(qū)域與成人哮喘之間的相關(guān)性,我們從山東大學(xué)齊魯醫(yī)院呼吸科收集了710例無(wú)親緣關(guān)系的成人哮喘患者,以及從健康體檢中心隨機(jī)收集了656例無(wú)親緣關(guān)系、無(wú)哮喘病及其它呼吸道疾病及過(guò)敏病史的健康體檢者作為對(duì)照組。根據(jù)相關(guān)報(bào)道及中國(guó)人群中該區(qū)域的連鎖不平衡情況,我們從17q21區(qū)域選取了5個(gè)單核苷酸多態(tài)位點(diǎn)(SNP):rs7216389, rs12603332, rs12936231, rs9303277, rs11557467進(jìn)行基于群體的病例對(duì)照關(guān)聯(lián)分析。 結(jié)果發(fā)現(xiàn)這5個(gè)SNP多態(tài)位點(diǎn)均與成人哮喘顯著相關(guān)(P0.05),其中兩個(gè)SNP多態(tài)位點(diǎn)rs9303277, rs11557467與成人哮喘的相關(guān)性最強(qiáng)(P0.001)。帶有rs11557467位點(diǎn)G等位基因的個(gè)體或者rs9303277位點(diǎn)C等位基因的個(gè)體的哮喘患病風(fēng)險(xiǎn)顯著升高(OR=1.27,95%CI1.07-1.51, P=0.006以及OR=1.27,95%CI1.07-1.49,P=0.005)。即使是在去除性別和年齡的影響以后,這種相關(guān)性仍然存在。此外,單體型分析發(fā)現(xiàn),與單體型TCCCG相比,單體型CTGTT且有保護(hù)效應(yīng),OR=0.81,95%CI0.67-0.97, P=0.02。 因此,本部分研究結(jié)果表明：ORMDL3基因所在的17q21區(qū)域中的遺傳多態(tài)在中國(guó)漢族人群中與成人哮喘顯著相關(guān)。 第二部分17q21區(qū)域?qū)е孪赘械墓δ躍NP的鑒定 由于在Ensembl數(shù)據(jù)庫(kù)中顯示ORMDL3基因具有2種轉(zhuǎn)錄本形式：ENST00000304046(ORMDL3-001)以及ENST00000394169(ORMDL3-002),并且這兩個(gè)轉(zhuǎn)錄本的編碼區(qū)域是完全相同的,不同的只是非翻譯區(qū),因此它們所編碼的蛋白質(zhì)是完全一樣的。那么在人體中,ORMDL3基因是以哪一種轉(zhuǎn)錄本形式存在呢?另外,Moffatt等人的研究發(fā)現(xiàn),在EB病毒感染的哮喘兒童的淋巴母細(xì)胞系中17q21區(qū)域中的遺傳多態(tài)與ORMDL3基因的表達(dá)水平密切相關(guān),因而提示遺傳多態(tài)調(diào)節(jié)ORMDL3基因表達(dá)的異常很可能在哮喘的發(fā)生中起著一定的作用。但是到目前為止,已經(jīng)發(fā)現(xiàn)的該區(qū)域中與哮喘相關(guān)的SNP中沒(méi)有一個(gè)是位于ORMDL3基因的編碼區(qū),而我們第一部分選取的SNP位點(diǎn)rs12603332恰好位于該基因的第一內(nèi)含子中,而已有報(bào)道提示位于內(nèi)含子中的遺傳多態(tài)可能會(huì)影響特定細(xì)胞或組織中基因的轉(zhuǎn)錄剪接。因此,我們首先檢測(cè)了ORMDL3基因在人體不同組織中所使用的轉(zhuǎn)錄本形式以及該基因第一內(nèi)含子中的一個(gè)SNP位點(diǎn)rs12603332的不同等位基因是否影響ORMDL3基因mRNA的剪接。 我們選取rs12603332位點(diǎn)基因型為CC及TT的個(gè)體各5例,同時(shí)選取人體肝臟組織,食管癌組織,大腸癌組織以及肺組織各12例,分別提取DNA和RNA。另外,根據(jù)兩個(gè)轉(zhuǎn)錄本的剪接特點(diǎn)設(shè)計(jì)引物,用PCR擴(kuò)增的方法進(jìn)行檢測(cè)：一對(duì)引物能同時(shí)擴(kuò)增出ORMDL3的兩種轉(zhuǎn)錄本形式,用以確定ORMDL3基因是否表達(dá)同時(shí)監(jiān)控cDNA的質(zhì)量,另一對(duì)引物只能擴(kuò)增出第二轉(zhuǎn)錄本,用于檢測(cè)第二轉(zhuǎn)錄本是否存在。結(jié)果顯示,在人體外周血淋巴細(xì)胞、肝臟組織、食管癌組織、大腸癌組織以及肺組織中都只表達(dá)ORMDL3基因的第一轉(zhuǎn)錄本形式：ENST00000304046(ORMDL3-001),并且不論是CC基因型還是TT基因型(rs12603332位點(diǎn))的個(gè)體都只表達(dá)第一轉(zhuǎn)錄本。因此,rs12603332位點(diǎn)并不影響ORMDL3基因的剪接,那么,該區(qū)域中的遺傳多態(tài)導(dǎo)致哮喘的機(jī)制是什么呢?哪個(gè)位點(diǎn)才是真正的功能位點(diǎn)呢? 由于基因轉(zhuǎn)錄水平的改變是介導(dǎo)哮喘或其他疾病易感的一個(gè)非常重要的機(jī)制,并且基因轉(zhuǎn)錄豐度很可能受到某些改變轉(zhuǎn)錄因子結(jié)合的SNP多態(tài)位點(diǎn)的直接影響。因此,我們檢測(cè)了哮喘患者和正常對(duì)照中ORMDL3基因和GSDMB基因的表達(dá)情況。從山東大學(xué)齊魯醫(yī)院呼吸科收集了61例確診的成人哮喘患者以及70例正常體檢個(gè)體的新鮮外周血,提取DNA及RNA,運(yùn)用實(shí)時(shí)定量PCR的方法進(jìn)行等位基因差異表達(dá)分析。結(jié)果發(fā)現(xiàn),哮喘患者外周血淋巴細(xì)胞中ORMDL3基因以及GSDMB基因的表達(dá)水平顯著高于正常對(duì)照個(gè)體,P0.05,并且攜帶有rs7216389,rs12603332以及rs12936231位點(diǎn)危險(xiǎn)等位基因的個(gè)體,其ORMDL3和GSDMB基因的表達(dá)水平顯著升高,P值均小于0.05。 因此,本部分研究結(jié)果表明：首先,在人體外周血淋巴細(xì)胞、肝臟組織、食管癌組織、大腸癌組織以及肺組織中,ORMDL3基因以第一轉(zhuǎn)錄本的形式存在,并且該基因第一內(nèi)含子中rs12603332位點(diǎn)的不同等位基因并不影響ORMDL3基因mRNA的剪接。其次,成人哮喘患者外周血淋巴細(xì)胞中ORMDL3及GSDMB基因的表達(dá)水平明顯高于正常對(duì)照,并且17q21區(qū)域中與哮喘相關(guān)的遺傳多態(tài)的危險(xiǎn)等位基因能顯著升高這兩個(gè)基因的表達(dá)水平。因此,ORMDL3及GSDMB基因的表達(dá)異常很可能是該區(qū)域誘發(fā)哮喘的潛在機(jī)制。但由于17q21區(qū)域是一個(gè)強(qiáng)連鎖不平衡的區(qū)域,從中篩選出具體的功能位點(diǎn)尚有待于更多的研究來(lái)證實(shí)。 第三部分ORMDL3基因基本啟動(dòng)子的鑒定 第二部分研究結(jié)果表明,ORMDL3基因的表達(dá)異常很可能是導(dǎo)致哮喘發(fā)生的原因之一,而關(guān)于該基因的轉(zhuǎn)錄調(diào)控機(jī)制目前尚不明確,因此在本部分中我們對(duì)該基因的基本啟動(dòng)子進(jìn)行了分析。 首先,我們克隆了ORMDL3基因轉(zhuǎn)錄起始點(diǎn)至上游約1.5kb的區(qū)域,連入pGL3basic載體中,用雙熒光素酶報(bào)告基因系統(tǒng)分析其啟動(dòng)子活性。此后運(yùn)用系列截短的辦法尋找包含ORMDL3基因基本啟動(dòng)子的最小區(qū)域。結(jié)果發(fā)現(xiàn),當(dāng)我們把序列從-68bp截短到-62bp時(shí),熒光素酶活性迅速下降了70%到80%,表明影響ORMDL3基因啟動(dòng)子活性的反應(yīng)元件應(yīng)該位于-68bp到-62bp之間。為了明確哪個(gè)轉(zhuǎn)錄因子結(jié)合在這一區(qū)域中影響ORMDL3基因的啟動(dòng)子活性,我們用轉(zhuǎn)錄因子預(yù)測(cè)軟件TESS進(jìn)行分析,結(jié)果發(fā)現(xiàn)在轉(zhuǎn)錄起始點(diǎn)上游-64bp到-56bp區(qū)域之間存在一個(gè)信號(hào)轉(zhuǎn)導(dǎo)及激活轉(zhuǎn)錄因子6(STAT6)的結(jié)合位點(diǎn)。EMSA及super shift實(shí)驗(yàn)表明,在體外情況下STAT6能結(jié)合在ORMDL3基因的啟動(dòng)子上。同時(shí)ChIP實(shí)驗(yàn)也表明,在體內(nèi)情況下STAT6也能結(jié)合在ORMDL3基因的啟動(dòng)子上。 本部分實(shí)驗(yàn)結(jié)果表明,ORMDL3基因的基本啟動(dòng)子區(qū)域位于轉(zhuǎn)錄起始點(diǎn)上游-68bp以內(nèi),并且轉(zhuǎn)錄起始點(diǎn)上游-64bp到-56bp區(qū)域之間的一個(gè)信號(hào)轉(zhuǎn)導(dǎo)及激活轉(zhuǎn)錄因子6(STAT6)的結(jié)合位點(diǎn)對(duì)ORMDL3基因的基本啟動(dòng)子活性起主要作用。 第四部分STAT6對(duì)ORMDL3基因的表達(dá)調(diào)控作用 既然ORMDL3基因啟動(dòng)子區(qū)域中的STAT6結(jié)合位點(diǎn)對(duì)ORMDL3基因的基本啟動(dòng)子活性起主要作用,那么STAT6對(duì)ORMDL3基因的表達(dá)調(diào)控作用具體是怎樣的呢?為此,我們構(gòu)建了STAT6的表達(dá)載體,在Jurkat細(xì)胞中分別轉(zhuǎn)染STAT6的表達(dá)載體或者STAT6的siRNA,結(jié)果發(fā)現(xiàn)STAT6的高表達(dá)或者低表達(dá)能顯著轉(zhuǎn)錄激活或者轉(zhuǎn)錄抑制ORMDL3基因基本啟動(dòng)子的熒光素酶報(bào)告基因活性及內(nèi)源性O(shè)RMDL3基因mRNA的表達(dá)。由于STAT6是一個(gè)受細(xì)胞因子IL-4/IL-13調(diào)控的轉(zhuǎn)錄因子,那么ORMDL3基因的表達(dá)是否也受IL-4/IL-13的調(diào)控呢?因此,我們還檢測(cè)了IL-4/IL-13對(duì)ORMDL3基因表達(dá)的影響,結(jié)果發(fā)現(xiàn)IL-4/IL-13處理能顯著激活ORMDL3基因啟動(dòng)子的熒光素酶報(bào)告基因活性及內(nèi)源性O(shè)RMDL3基因mRNA的表達(dá),而一旦干擾了STAT6,這一現(xiàn)象就會(huì)消失,表明IL-4/IL-13對(duì)ORMDL3基因的表達(dá)調(diào)控作用依賴于STAT6。另外,有研究發(fā)現(xiàn)p300也能結(jié)合在ORMDL3基因的啟動(dòng)子上,并且它的結(jié)合位點(diǎn)與我們發(fā)現(xiàn)的STAT6結(jié)合位點(diǎn)基本一致。因此,我們進(jìn)行了ChIP實(shí)驗(yàn),結(jié)果發(fā)現(xiàn)p300確實(shí)也能結(jié)合在ORMDL3基因的啟動(dòng)子上。于是我們又進(jìn)一步進(jìn)行了IP實(shí)驗(yàn)和ChIP-Re-ChIP實(shí)驗(yàn),結(jié)果發(fā)現(xiàn)p300和STAT6能相互結(jié)合,并且它們是以復(fù)合物的形式結(jié)合在ORMDL3基因的啟動(dòng)子上。事實(shí)上,p300是一個(gè)協(xié)同轉(zhuǎn)錄因子,它并不直接結(jié)合在DNA序列上,而是通過(guò)與其他序列特異的轉(zhuǎn)錄因子結(jié)合而被招募到啟動(dòng)子上。 因此,本部分研究結(jié)果表明,轉(zhuǎn)錄因子STAT6能轉(zhuǎn)錄激活ORMDL3基因的表達(dá),并且IL-4/IL-13處理能顯著激活ORMDL3基因的啟動(dòng)子活性及內(nèi)源性O(shè)RMDL3基因mRNA的表達(dá),并且這種激活作用依賴于STAT6。事實(shí)上,轉(zhuǎn)錄因子STAT6通過(guò)招募協(xié)同轉(zhuǎn)錄因子p300,共同調(diào)控ORMDL3基因的表達(dá)。這一研究為ORMDL3與炎癥及哮喘相關(guān)的事實(shí)提供了一個(gè)合理的解釋,同時(shí)也為臨床上預(yù)防和治療哮喘提供了一個(gè)新的途徑。
[Abstract]:Asthma is a complex disease caused by environmental and genetic factors. The heritability of asthma is about 36% - 79%. In 2007, the first genome-wide association analysis of asthma revealed a new susceptibility gene, ORMDL3. Researchers found that genetic polymorphisms in the 17q21 region of ORMDL3 were significantly associated with childhood asthma. Furthermore, the genetic polymorphism in this region is also closely related to the expression of ORMDL3 gene in the lymphoblastoid cell lines of asthmatic children infected with EBV.
ORMDL3 gene, located at 17q21, is a member of the ORM gene family. In yeast, ORMDL1 and ORMDL2 are members of the ORMDL3 family, while in humans there are three members of the ORMDL3 family. Transsphingomyelin metabolism may play an important role in the development of asthma. In addition, the knockout of ORM gene in yeast may result in slow growth and increased sensitivity to toxic substances. This phenomenon was saved by transfection of human ORMDL3 gene into the mRNA. ORMDL3 gene encodes an endoplasmic reticulum containing 153 amino acids four times across the membrane. ORMDL3 is widely expressed in human tissues, especially in the liver and peripheral blood lymphocytes. Studies have shown that ORMDL3 co-localizes with calcium pumps in the endoplasmic reticulum, inhibits the function of calcium pumps, affects the balance of calcium ions, and promotes endoplasmic reticulum stress and unfolded protein responses, suggesting that ORMDL3 may be involved in endoplasmic reticulum-related inflammation. In addition, genetic polymorphisms in the 17q21 region of cord blood mononuclear cells in children were found to be associated not only with the expression of ORMDL3 and GSDMA genes, but also with the secretion of IL-17, suggesting that the region may be associated with the development and differentiation of T cells in the early stage of immune system maturation. In addition to asthma, the region is associated with human development. ORMDL3 was also found to be significantly associated with various inflammatory diseases such as Crohn's disease, ankylosing spondylitis, systemic lupus erythematosus, type 1 diabetes mellitus, glioma, primary biliary cirrhosis, and allergic rhinitis.
Since ORMDL3 was found to be a new susceptible gene for asthma, it has been tested in a very short period of time in a number of different ethnic groups. It has been found that ORMDL3 gene is significantly associated with childhood asthma in different populations. What about asthma? The genetic polymorphism of 17q21 in EBV-infected asthmatic children's lymphoblasts is associated with the expression of ORMDL3 gene. Is this still present in the peripheral blood lymphocytes of adult asthmatic patients? How is the abnormal expression of ORMDL3 gene in asthmatic patients caused? With these problems, this paper carries out the following four aspects of research:
Part one association analysis between 17q21 area and asthma in Chinese Han Adults
To clarify the relationship between the 17q21 region of ORMDL3 gene and adult asthma, 710 unrelated adult patients with asthma were collected from the Respiratory Department of Qilu Hospital of Shandong University, and 656 unrelated, non-asthmatic and other respiratory diseases and allergies were randomly collected from the Health Examination Center. Based on the related reports and linkage disequilibrium in the Chinese population, five single nucleotide polymorphisms (SNPs) were selected from the 17q21 region: rs7216389, rs12603332, rs12936231, rs9303277, and rs11557467 for population-based case-control association analysis.
The results showed that the five SNP polymorphisms were significantly associated with adult asthma (P 0.05). Two SNP polymorphisms, rs9303277 and rs11557467, had the strongest association with adult asthma (P 0.001). Individuals with the G allele at rs11557467 or the C allele at rs9303277 had a significantly increased risk of asthma (OR = 1.27, 95% CI 1.0). 7-1.51, P = 0.006 and OR = 1.27, 95% CI 1.07-1.49, P = 0.005). Even after removing the influence of sex and age, this correlation still exists. In addition, haplotype analysis showed that CTGTT had protective effect compared with TCCCG, OR = 0.81, 95% CI 0.67-0.97, P = 0.02.97.
Therefore, the results of this study indicate that the genetic polymorphisms in the 17q21 region of ORMDL3 gene are significantly associated with adult asthma in Chinese Han population.
The second part is the identification of functional SNP in asthma caused by 17q21 region.
Because ORMDL3 gene has two transcript forms in the Ensembl database: ENST00000304046 (ORMDL3-001) and ENST00000394169 (ORMDL3-002), and the coding regions of the two transcripts are identical, but the difference is only the untranslated region, so the protein they encode is identical. In addition, Moffatt et al. found that genetic polymorphism in the 17q21 region of the lymphoblastoid cell line of asthmatic children infected with EBV was closely related to the expression level of ORMDL3 gene, suggesting that the abnormal expression of ORMDL3 gene regulated by genetic polymorphism may be involved in the development of asthma. But so far, none of the asthma-related SNPs in this region is located in the coding region of ORMDL3 gene, and the SNP locus rs12603332 selected in the first part of our study happens to be located in the first intron of the gene. It has been reported that the genetic polymorphism in the intron may be affected. Therefore, we first examined the transcriptional form of ORMDL3 gene used in different tissues of the human body and whether the different alleles of rs12603332, a SNP locus in the first intron of the gene, affected the splicing of ORMDL3 gene mRNA.
DNA and RNA were extracted from human liver, esophageal cancer, colorectal cancer and lung tissues, respectively. In addition, primers were designed according to the splicing characteristics of the two transcripts. PCR amplification was used to detect ORMDL. The results showed that ORMDL3 was only expressed in human peripheral blood lymphocytes, liver tissue, esophageal cancer tissue, colorectal cancer tissue and lung tissue in vitro. The first transcript form of the gene: ENST00000304046 (ORMDL3-001), and individuals of either CC genotype or TT genotype (rs12603332 locus) only express the first transcript. Therefore, rs12603332 locus does not affect the splicing of ORMDL3 gene, so what is the mechanism of genetic polymorphism in this region leading to asthma? Is it a real functional site?
Because changes in gene transcription levels are a very important mechanism mediating susceptibility to asthma or other diseases, and gene transcription abundance is likely to be directly affected by some SNP polymorphisms that alter transcription factor binding, we examined the expression of ORMDL3 and GSDMB genes in asthmatic patients and controls. Fresh peripheral blood samples from 61 patients with asthma and 70 normal subjects were collected from the Department of Respiration, Qilu Hospital, Shandong University. DNA and RNA were extracted and analyzed by real-time quantitative PCR. The expression levels of ORMDL3 and GSDMB genes were significantly higher in individuals with rs7216389, rs12603332 and rs12936231 loci than in controls (P 0.05).
Therefore, the results of this study show that: firstly, ORMDL3 gene exists as the first transcript in human peripheral blood lymphocytes, liver, esophageal cancer, colorectal cancer and lung tissues, and the different alleles of rs12603332 in the first intron of ORMDL3 gene do not affect the splicing of ORMDL3 gene mRNA. The expression levels of ORMDL3 and GSDMB genes in peripheral blood lymphocytes of adult asthmatic patients were significantly higher than those of normal controls, and the risk allele of asthma-related genetic polymorphism in 17q21 region could significantly increase the expression levels of these two genes. However, because the 17q21 region is a strong linkage disequilibrium region, screening specific functional sites from it needs more research to confirm.
The third part is the identification of the basic promoter of ORMDL3 gene.
The second part of the study showed that the abnormal expression of ORMDL3 gene may be one of the causes of asthma, and the transcriptional regulation mechanism of ORMDL3 gene is still unclear, so we analyzed the basic promoter of ORMDL3 gene in this part.
Firstly, we cloned the region from the transcription starting point of ORMDL3 gene to about 1.5 KB upstream, then inserted it into the pGL3 basic vector and analyzed its promoter activity with a dual luciferase reporter gene system. Then we used a series of truncation methods to find the smallest region containing the basic promoter of ORMDL3 gene. At 62 bp, the activity of luciferase decreased by 70% to 80%, indicating that the response element affecting the activity of ORMDL3 promoter should be located between - 68 BP and - 62 bp. There is a signal transduction and activation transcription factor 6 (STAT6) binding site between - 64 BP and - 56 bp upstream of the starting point. EMSA and super shift experiments show that STAT6 can bind to the promoter of ORMDL3 gene in vitro. ChIP experiments also show that STAT6 can bind to the promoter of ORMDL3 gene in vivo.
The results showed that the basic promoter region of ORMDL3 gene was located within - 68 bp upstream of the transcription initiation point, and a signal transduction and activation transcription factor 6 (STAT6) binding site between - 64 BP and - 56 bp upstream of the transcription initiation point played a major role in the basic promoter activity of ORMDL3 gene.
The fourth part is the regulation of ORMDL3 gene expression by STAT6.
Since STAT6 binding sites in the promoter region of ORMDL3 gene play a major role in the basic promoter activity of ORMDL3 gene, how does STAT6 regulate the expression of ORMDL3 gene? For this reason, we constructed the expression vector of STAT6 and transfected STAT6 expression vector or STAT6 siRNA in Jurkat cells, respectively. It was found that high or low expression of STAT6 could significantly activate or suppress the activity of luciferase reporter gene and the expression of endogenous ORMDL3 gene mRNA in the basic promoter of ORMDL3 gene. Since STAT6 is a transcription factor regulated by cytokine IL-4/IL-13, the expression of ORMDL3 gene is also regulated by IL-4/IL-13. Therefore, we also examined the effect of IL-4/IL-13 on ORMDL3 gene expression, and found that IL-4/IL-13 treatment significantly activated the luciferase reporter gene activity of ORMDL3 gene promoter and the expression of endogenous ORMDL3 gene mRNA. Once STAT6 was interfered with, this phenomenon would disappear, indicating that IL-4/IL-13 on ORMDL3 gene expression. In addition, some studies have found that P300 can bind to the promoter of ORMDL3 gene, and its binding site is basically the same as the STAT6 binding site we found. Therefore, we carried out ChIP experiments and found that P300 can indeed bind to the promoter of ORMDL3 gene. IP experiment
【學(xué)位授予單位】：山東大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2013
【分類號(hào)】：R562.25

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 邱艷紅,王根娣,李云珠;哮喘兒童吸入激素治療前后生命質(zhì)量評(píng)估[J];臨床兒科雜志;2001年06期

2 孔元原,孫明明;哮喘兒童行為問(wèn)題研究[J];貴陽(yáng)醫(yī)學(xué)院學(xué)報(bào);2001年03期

3 林茂英,任榕娜,曹惠琴,葉禮燕;哮喘兒童氣質(zhì)類型與社會(huì)生活能力關(guān)系的研究及干預(yù)措施[J];東南國(guó)防醫(yī)藥;2002年02期

4 陳洪杰,吳蓓鈺,繆海中;3～13歲哮喘兒童急性發(fā)作誘因調(diào)查[J];河北醫(yī)藥;2003年07期

5 劉麗云,魏玉英;哮喘兒童的門診健康教育[J];中國(guó)鄉(xiāng)村醫(yī)藥;2003年04期

6 劉力行,鄭菊映;持續(xù)護(hù)理干預(yù)對(duì)霧化吸入治療小兒哮喘過(guò)程[J];現(xiàn)代臨床醫(yī)學(xué)生物工程學(xué)雜志;2005年04期

7 吳秋玲;口服單劑強(qiáng)的松龍治療兒童急性哮喘[J];新醫(yī)學(xué);1988年05期

8 施毅;應(yīng)用x線密度測(cè)定評(píng)價(jià)二丙酸氯地米松對(duì)哮喘兒童骨有機(jī)物含量的作用[J];國(guó)外醫(yī)學(xué).呼吸系統(tǒng)分冊(cè);1994年04期

9 王世榮,王光慧,崔潤(rùn)海,王春玲,周信英,劉友芬;哮喘兒童外周血淋巴細(xì)胞亞群與血清總IgE關(guān)系的探討[J];天津醫(yī)藥;1995年01期

10 馬文成,朱美華;兒童哮喘病人的TNFβ基因遺傳多態(tài)性[J];現(xiàn)代臨床醫(yī)學(xué)生物工程學(xué)雜志;2005年03期

相關(guān)會(huì)議論文 前10條

1 周瑩;邵潔;;家庭香煙煙霧暴露與哮喘兒童疾病控制狀態(tài)相關(guān)性研究[A];中華醫(yī)學(xué)會(huì)2011年全國(guó)變態(tài)反應(yīng)學(xué)術(shù)會(huì)議論文集[C];2011年

2 湯正珍;劉萍;鄭躍杰;;哮喘兒童吸入糖皮質(zhì)激素治療的回顧性研究[A];中華醫(yī)學(xué)會(huì)2011年全國(guó)變態(tài)反應(yīng)學(xué)術(shù)會(huì)議論文集[C];2011年

3 唐芙蓉;;哮喘兒童過(guò)敏原檢測(cè)及早期干預(yù)[A];全國(guó)兒科護(hù)理學(xué)術(shù)交流會(huì)議論文匯編[C];2011年

4 湯正珍;鄭躍杰;;哮喘兒童吸入糖皮質(zhì)激素后5年過(guò)敏原變化[A];中華醫(yī)學(xué)會(huì)2011年全國(guó)變態(tài)反應(yīng)學(xué)術(shù)會(huì)議論文集[C];2011年

5 趙秀勉;;淺析對(duì)哮喘兒童及其家長(zhǎng)的健康教育[A];全國(guó)兒科護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2003年

6 黃東明;肖曉雄;駱翠媚;李嵐;王克明;馮垣輝;汪葉紅;崔碧云;黃桂珍;阮健;鄭伯強(qiáng);付四毛;;哮喘和健康兒童吸入性過(guò)敏原皮膚點(diǎn)刺試驗(yàn)的對(duì)比研究[A];中華醫(yī)學(xué)會(huì)2011年全國(guó)變態(tài)反應(yīng)學(xué)術(shù)會(huì)議論文集[C];2011年

7 施樂(lè);陳偉斌;;哮喘兒童體質(zhì)的研究概況[A];第28次全國(guó)中醫(yī)兒科學(xué)術(shù)大會(huì)暨2011年名老中醫(yī)治療（兒科）疑難病臨床經(jīng)驗(yàn)高級(jí)專修班論文匯編[C];2011年

8 劉齊元;朱騰義;程元強(qiáng);范東東;;煙草atp6基因SNP的錯(cuò)配堿基法檢測(cè)及其與CMS的相關(guān)性[A];2010中國(guó)作物學(xué)會(huì)學(xué)術(shù)年會(huì)論文摘要集[C];2010年

9 羅榮華;王次林;;400例哮喘兒童變應(yīng)原皮試結(jié)果分析[A];第一屆全國(guó)變態(tài)反應(yīng)學(xué)術(shù)研討會(huì)論文匯編[C];2001年

10 陳磊;郭亦杰;周繼鵬;李慕朋;王英;李元建;陳小平;;中國(guó)漢族人群DDAH1功能性SNP的研究及對(duì)ADMA代謝的影響[A];中國(guó)藥理學(xué)會(huì)第十一次全國(guó)學(xué)術(shù)會(huì)議�？痆C];2011年

相關(guān)重要報(bào)紙文章 前10條

1 中國(guó)疾控中心環(huán)境所研究員 徐東群;潔凈室內(nèi)環(huán)境讓孩子遠(yuǎn)離哮喘[N];健康報(bào);2010年

2 健康時(shí)報(bào)記者 馮麗安　特約記者 康芳琴;治哮喘兒童時(shí)期最關(guān)鍵[N];健康時(shí)報(bào);2009年

3 王山;哮喘兒童 家庭護(hù)理有學(xué)問(wèn)[N];中國(guó)中醫(yī)藥報(bào);2009年

4 上海岳陽(yáng)中西醫(yī)結(jié)合醫(yī)院兒科 陳偉斌 副主任醫(yī)師;哮喘兒童的日常生活保健[N];上海中醫(yī)藥報(bào);2010年

5 徐錚奎;哮喘兒童不宜多吃麥淇淋[N];大眾衛(wèi)生報(bào);2002年

6 黃秀清;盛夏需防“冷”過(guò)敏[N];保健時(shí)報(bào);2003年

7 黃秀清;盛夏需防“冷”過(guò)敏[N];中國(guó)中醫(yī)藥報(bào);2003年

8 記者 劉海英;公共場(chǎng)所禁煙惠及每一人[N];科技日?qǐng)?bào);2010年

9 北京協(xié)和醫(yī)院變態(tài)反應(yīng)科副主任醫(yī)師 支玉香;家養(yǎng)寵物 難逃過(guò)敏[N];健康報(bào);2009年

10 Marvin;測(cè)基因而知天命？[N];經(jīng)濟(jì)觀察報(bào);2009年

相關(guān)博士學(xué)位論文 前10條

1 邱熔芳;ORMDL3在哮喘發(fā)生中的作用及其轉(zhuǎn)錄調(diào)控機(jī)制研究[D];山東大學(xué);2013年

2 李艷春;白細(xì)胞介素-23對(duì)哮喘小鼠記憶T細(xì)胞增殖功能的影響[D];吉林大學(xué);2013年

3 周衛(wèi)芳;藥物和低劑量照射干預(yù)哮喘免疫調(diào)節(jié)機(jī)制的探討[D];蘇州大學(xué);2011年

4 蘇奎國(guó);五紫三黃方對(duì)激素依賴性哮喘小鼠模型作用機(jī)理的實(shí)驗(yàn)研究[D];北京中醫(yī)藥大學(xué);2012年

5 劉艷明;哮喘小鼠氣道白細(xì)胞介素-6、信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子3的表達(dá)與活化及其作用[D];廣西醫(yī)科大學(xué);2010年

6 劉紹坤;RNA干擾GATA-3基因表達(dá)對(duì)急性哮喘小鼠Th17細(xì)胞分化及致炎機(jī)能的影響[D];中南大學(xué);2010年

7 楊沫毅;急性哮喘小鼠中T-bet通過(guò)IL-23受體對(duì)Th17細(xì)胞增殖和致炎機(jī)能的影響[D];中南大學(xué);2010年

8 吳小慧;支氣管哮喘相關(guān)基因的多態(tài)性研究[D];華中科技大學(xué);2010年

9 田金娜;活血定喘湯對(duì)哮喘小鼠氣道重塑的實(shí)驗(yàn)研究[D];成都中醫(yī)藥大學(xué);2010年

10 遲翔宇;ADAM33基因在支氣管哮喘發(fā)病中的研究[D];山東大學(xué);2011年

相關(guān)碩士學(xué)位論文 前10條

1 黃漢琮;ORMDL3基因rs7216389位點(diǎn)多態(tài)性與哮喘相關(guān)性研究[D];南昌大學(xué);2011年

2 陽(yáng)愛(ài)梅;湖南省哮喘兒童ORMDL3基因多態(tài)性分析及與OPN、TGF-β1水平相關(guān)性探討[D];中南大學(xué);2012年

3 王倩;游戲治療取向團(tuán)體輔導(dǎo)在哮喘兒童心理應(yīng)對(duì)能力訓(xùn)練中的應(yīng)用[D];重慶醫(yī)科大學(xué);2011年

4 吳丹遐;恐懼應(yīng)激與實(shí)驗(yàn)大鼠哮喘相關(guān)性的研究[D];南昌大學(xué);2011年

5 徐同福;哮喘疾病中鋅轉(zhuǎn)運(yùn)體表達(dá)的初步研究[D];山東大學(xué);2010年

6 劉芳;哮喘對(duì)學(xué)齡期兒童認(rèn)知功能影響的研究[D];中國(guó)醫(yī)科大學(xué);2010年

7 湯正珍;哮喘兒童吸入糖皮質(zhì)激素治療的回顧性研究[D];遵義醫(yī)學(xué)院;2011年

8 胡平;哮喘兒童（7-17歲）自我管理量表的編制及應(yīng)用[D];重慶醫(yī)科大學(xué);2011年

9 徐丹;哮喘黏膜免疫過(guò)程中“肺開竅于鼻”理論的體現(xiàn)[D];新疆醫(yī)科大學(xué);2010年

10 劉娜;學(xué)齡期哮喘兒童自我管理行為的干預(yù)效果研究[D];中國(guó)協(xié)和醫(yī)科大學(xué);2010年

，

本文編號(hào)：2180431